Effects of short IV infusions of DT-009, a novel adenosine (A?) receptor agonist, on renal function in healthy subjects

2005 ◽  
Vol 77 (2) ◽  
pp. P58-P58
Author(s):  
J VENITZ ◽  
D SICA ◽  
R TOWNSEND ◽  
M DESSIMOZ
2001 ◽  
Vol 59 (5) ◽  
pp. 1873-1880 ◽  
Author(s):  
Albertus J. Voogel ◽  
Marion G. Koopman ◽  
Augustinus A.M. Hart ◽  
Gert A. Van Montfrans ◽  
Lambertus Arisz

PLoS ONE ◽  
2015 ◽  
Vol 10 (6) ◽  
pp. e0129036 ◽  
Author(s):  
Mika Baba ◽  
Takuro Shimbo ◽  
Masaru Horio ◽  
Masahiko Ando ◽  
Yoshinari Yasuda ◽  
...  

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 104-OR
Author(s):  
SHWETA URVA ◽  
YU DU ◽  
MELISSA K. THOMAS ◽  
ZVONKO MILICEVIC ◽  
TAMER COSKUN ◽  
...  

1997 ◽  
Vol 41 (7) ◽  
pp. 1562-1565 ◽  
Author(s):  
S C Chien ◽  
A T Chow ◽  
J Natarajan ◽  
R R Williams ◽  
F A Wong ◽  
...  

The influence of age and gender on the pharmacokinetics of levofloxacin in healthy subjects receiving a single oral 500-mg dose of levofloxacin was investigated in this parallel design study. Six young males (aged 18 to 40 years), six elderly males (aged > or = 65 years), six young females (aged 18 to 40 years), and six elderly females (aged > or = 65 years) were enrolled and completed the study. The study reveals that the bioavailability (rate and extent) of levofloxacin was not affected by either age or gender. In both age (young and elderly) and gender (male and female) groups of subjects, peak concentrations in plasma were reached at approximately 1.5 h after dosing; renal clearance of levofloxacin accounted for approximately 77% of total body clearance, and approximately 76% of the administered dose was recovered unchanged in urine over the 36 h of collection. The apparent differences in the calculated pharmacokinetic parameters for levofloxacin between the age groups (young versus elderly) and between the gender groups (males versus females) could be explained by differences in renal function among the subjects. A single dose of 500 mg of levofloxacin administered orally to both young and old, male and female healthy subjects was found to be safe and well tolerated. As the differences in levofloxacin kinetics between the young and the elderly or the males and the females are limited and are mainly related to the renal function of the subjects, dose adjustment based on age or gender alone is not necessary.


2016 ◽  
Vol 150 (4) ◽  
pp. S194
Author(s):  
Su Youn Nam ◽  
Seong Bok Jang ◽  
Mi Kyung Kim ◽  
Jong Ryul Kim ◽  
Jin-Ah Jung ◽  
...  

2017 ◽  
Vol 43 (06) ◽  
pp. 621-628 ◽  
Author(s):  
Gian Salvagno ◽  
Elisa Danese ◽  
Giorgio Brocco ◽  
Matteo Gelati ◽  
Martina Montagnana ◽  
...  

AbstractGrowth differentiation factor-15 (GDF-15) has recently emerged as a strong and independent predictor of cardiovascular events and mortality. However, the pathophysiological mechanisms underlying this important association remain speculative. This study was aimed to investigate the potential associations between the serum concentration of GDF-15 and clinical or laboratory parameters in a population of ostensibly healthy subjects. The study population consisted of 44 healthy volunteers enrolled from the laboratory staff (14 males and 30 females; mean age, 47 ± 11 years), who had their blood collected for assessing complete blood cell count, GDF-15, serum creatinine, albumin, cardiac troponin T, galectin-3, routine coagulation tests, D-dimer, von Willebrand factor, and platelet function testing using platelet function analyzer-100. In univariate analysis, serum GDF-15 was found to be positively associated with age and plasma fibrinogen, and negatively associated with renal function and collagen-epinephrine (CEPI). In multiple linear regression analysis, serum GDF-15 remained significantly associated with renal function, CEPI, and plasma fibrinogen. Healthy subjects with GDF-15 above the median value had a twofold probability of displaying shorter CEPI closure times. Taken together, these results suggest that higher serum values of GDF-15 may be associated with overall global platelet hyperactivity and increased plasma fibrinogen, so providing another plausible explanation for the association between GDF-15, cardiovascular events, and mortality.


Sign in / Sign up

Export Citation Format

Share Document